Martingale Asset Management L P boosted its holdings in SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) by 108.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 65,415 shares of the company’s stock after purchasing an additional 34,035 shares during the quarter. Martingale Asset Management L P’s holdings in SIGA Technologies were worth $442,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently added to or reduced their stakes in SIGA. Larson Financial Group LLC purchased a new stake in SIGA Technologies in the 3rd quarter valued at about $30,000. DekaBank Deutsche Girozentrale purchased a new stake in SIGA Technologies in the second quarter valued at approximately $40,000. China Universal Asset Management Co. Ltd. increased its position in SIGA Technologies by 64.3% during the third quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock worth $93,000 after purchasing an additional 5,372 shares during the last quarter. AQR Capital Management LLC purchased a new position in SIGA Technologies during the second quarter worth approximately $99,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of SIGA Technologies by 38.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock valued at $104,000 after purchasing an additional 3,829 shares during the last quarter. 55.40% of the stock is currently owned by hedge funds and other institutional investors.
SIGA Technologies Stock Down 7.1 %
SIGA stock opened at $6.64 on Wednesday. The company has a market cap of $474.10 million, a price-to-earnings ratio of 5.53 and a beta of 0.89. The business has a fifty day simple moving average of $6.92 and a 200-day simple moving average of $7.84. SIGA Technologies, Inc. has a 52 week low of $4.26 and a 52 week high of $12.83.
SIGA Technologies Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Recommended Stories
- Five stocks we like better than SIGA Technologies
- Quiet Period Expirations Explained
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- What is Put Option Volume?
- Netflix Is On Track To Hit $1,000 By Christmas
- Consumer Staples Stocks, Explained
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report).
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.